Compounds > ciglitazone

ciglitazone and dihydrotestosterone

ciglitazone has been researched along with dihydrotestosterone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CS; Ku, CY; Pinzone, JJ; Ringel, MD; Shiau, CW; Wei, S; Yang, CC1
Lyles, BE; Moss, PE; Stewart, LV1

Other Studies

2 other study(ies) available for ciglitazone and dihydrotestosterone

ArticleYear
Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.
    Molecular pharmacology, 2006, Volume: 69, Issue:5

    Topics: Animals; Cell Line, Tumor; Dihydrotestosterone; Humans; Male; Pioglitazone; PPAR gamma; Prostate-Specific Antigen; Prostatic Neoplasms; Thiazolidinediones; Transfection

2006
The PPARĪ³ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
    Experimental cell research, 2010, Dec-10, Volume: 316, Issue:20

    Topics: Androgen-Binding Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dihydrotestosterone; Gene Expression; Genes, Reporter; Humans; Hypoglycemic Agents; Male; Mutation; Neoplasms, Hormone-Dependent; PPAR gamma; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Transfection

2010